Amendment109th Congress
At the end of the bill (before the short title), insert the following: \ Sec. __. None of the funds made available in this Act may be used by the Council of Economic Advisers to produce an Economic Report of the President regarding the average cost of developing and introducing a new prescription drug to the market at $800 million or more.
- Amendment Number
- 434
- Description
- At the end of the bill (before the short title), insert the following: \ Sec. __. None of the funds made available in this Act may be used by the Council of Economic Advisers to produce an Economic Report of the President regarding the average cost of developing and introducing a new prescription drug to the market at $800 million or more.
- Purpose
- An amendment to prohibit the use of funds from being used by the Council of Economic Advisers to produce an Economic Report of the President regarding the average cost of developing and introducing a new prescription drug to the market at $800 million or more.
- Congress
- 109
- Type
- HAMDT
- Latest Action Date
- Jun 30, 2005
- Latest Action Text
- On agreeing to the Brown (OH) amendment (A041) Failed by recorded vote: 141 - 284 (Roll no. 355).
- Latest Action Time
- 18:28:06
- Submitted Date
- Jun 30, 2005
- Chamber
- House of Representatives
- Update Date
- Dec 5, 2020